Alembic FDA Friday, August 25, 2023 0.00 Neutral

FDA Approves BRIMONIDINE TARTRATE AND TIMOLOL MALEATE — Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited secured FDA approval for its generic Brimonidine Tartrate and Timolol Maleate ophthalmic solution, allowing the company to expand its product portfolio and capture additional market share within the growing ophthalmic segment.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day